Stanley C Erck - Net Worth and Insider Trading
Stanley C Erck Net Worth
The estimated net worth of Stanley C Erck is at least $1 Million dollars as of 2024-11-13. Stanley C Erck is the Director of MaxCyte Inc and owns about 269,118 shares of MaxCyte Inc (MXCT) stock worth over $952,678. Stanley C Erck is also the President and CEO of Novavax Inc and owns about 23,879 shares of Novavax Inc (NVAX) stock worth over $201,778. Details can be seen in Stanley C Erck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stanley C Erck has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stanley C Erck
Stanley C Erck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stanley C Erck owns 3 companies in total, including Novavax Inc (NVAX) , BioCryst Pharmaceuticals Inc (BCRX) , and MaxCyte Inc (MXCT) .
Click here to see the complete history of Stanley C Erck’s form 4 insider trades.
Insider Ownership Summary of Stanley C Erck
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVAX | Novavax Inc | 2021-10-04 | director & President and CEO |
| BCRX | BioCryst Pharmaceuticals Inc | 2008-12-22 | director |
| MXCT | MaxCyte Inc | 2024-11-01 | director |
Stanley C Erck Latest Holdings Summary
Stanley C Erck currently owns a total of 2 stocks. Among these stocks, Stanley C Erck owns 269,118 shares of MaxCyte Inc (MXCT) as of November 1, 2024, with a value of $952,678 and a weighting of 82.52%. Stanley C Erck also owns 23,879 shares of Novavax Inc (NVAX) as of October 4, 2021, with a value of $201,778 and a weighting of 17.48%.
Latest Holdings of Stanley C Erck
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MXCT | MaxCyte Inc | 2024-11-01 | 269,118 | 3.54 | 952,678 |
| NVAX | Novavax Inc | 2021-10-04 | 23,879 | 8.45 | 201,778 |
Holding Weightings of Stanley C Erck
Stanley C Erck Form 4 Trading Tracker
According to the SEC Form 4 filings, Stanley C Erck has made a total of 3 transactions in MaxCyte Inc (MXCT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in MaxCyte Inc is the sale of 47,689 shares on November 1, 2024, which brought Stanley C Erck around $177,403.
According to the SEC Form 4 filings, Stanley C Erck has made a total of 5 transactions in Novavax Inc (NVAX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Novavax Inc is the sale of 42,829 shares on October 4, 2021, which brought Stanley C Erck around $8 Million.
Insider Trading History of Stanley C Erck
- 1
Stanley C Erck Trading Performance
GuruFocus tracks the stock performance after each of Stanley C Erck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stanley C Erck is 6.38%. GuruFocus also compares Stanley C Erck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stanley C Erck within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stanley C Erck's insider trading performs compared to the benchmark.
Performance of Stanley C Erck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.29 | | | | | |
| Relative Return to S&P 500(%) | 7.33 | | | | | |
Stanley C Erck Ownership Network
Ownership Network List of Stanley C Erck
Ownership Network Relation of Stanley C Erck
Stanley C Erck Owned Company Details
What does Novavax Inc do?
Who are the key executives at Novavax Inc?
Stanley C Erck is the director & President and CEO of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .
Novavax Inc (NVAX) Insider Trades Summary
Over the past 18 months, Stanley C Erck made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net sale of 61,216 shares made by Filip Dubovsky , and a net sale of 15,000 shares made by James F Young .
In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,216 shares of Novavax Inc (NVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 76,216 shares.
Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Novavax Inc Insider Transactions
Stanley C Erck Mailing Address
Above is the net worth, insider trading, and ownership report for Stanley C Erck. You might contact Stanley C Erck via mailing address: 20 Firstfield Road, #250, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
